Literature DB >> 29362929

Does the efficacy of parent-child training depend on maternal symptom improvement? Results from a randomized controlled trial on children and mothers both affected by attention-deficit/hyperactivity disorder (ADHD).

Alexander Häge1, Barbara Alm2, Tobias Banaschewski3, Katja Becker3,4, Michael Colla5, Christine Freitag6,7, Julia Geissler8, Alexander von Gontard7, Erika Graf9, Barbara Haack-Dees10, Susann Hänig7, Klaus Hennighausen10, Sarah Hohmann3, Christian Jacob11,12, Charlotte Jaite13, Christine Jennen-Steinmetz14, Viola Kappel13, Swantje Matthies15, Alexandra Philipsen15,16, Luise Poustka3,17, Wolfgang Retz18,19, Michael Rösler18, Katja Schneider-Momm10, Esther Sobanski2,20, Timo D Vloet8, Andreas Warnke8, Thomas Jans8.   

Abstract

Multimodal treatment of children with ADHD often includes parent-child training (PCT). However, due to the high heritability, parents of children with ADHD are frequently also affected by the disorder, which is likely to constitute a significant barrier to successful treatment of the child. This secondary analysis of our randomized controlled multicentre AIMAC trial (ADHD in mothers and children) investigates whether children's outcomes following parent-child training in combination with maternal ADHD treatment depend on maternal symptom improvement. In a first step focusing on treatment of maternal ADHD, 144 mothers of mother-child dyads were randomized to multimodal ADHD treatment (group psychotherapy plus methylphenidate) or clinical management (mainly supportive counselling). After 12 weeks (T2), a 12-week PCT program (T2-T3) for all mother-child dyads was added to treat children's ADHD. Maternal symptomatology (CAARS-O:L; SCL-90-R) and children's externalizing symptoms (ADHD-ODD Scale, SDQ) were repeatedly assessed (T1 = baseline, T2, T3). Effects of changes in maternal symptomatology (T1-T2) on the change in children's symptom scores (T1-T3) were analysed using a general linear model, controlling for baseline scores, study centre, and maternal treatment group. 125 mother-child dyads were analysed. Mothers showed significant improvements in ADHD symptoms and overall psychopathology [CAARS-O:L ADHD index: mean - 3.54, SE 0.74 p < 0.0001; SCL-90-R Global Severity (GS): mean - 11.03, SE 3.90, p = 0.0056]. Although children's externalizing symptoms improved significantly (ADHD-ODD Scale: mean - 4.46, SE 0.58, p < 0.0001), maternal improvement had no effect on children's outcomes after Bonferroni-Holm correction for multiple testing. The findings do not support our hypothesis that children's outcomes following PCT for ADHD depend on maternal symptom improvements.Trial register CCT-ISRCTN73911400.

Entities:  

Keywords:  Maternal ADHD; Parent–child training; Treatment response

Mesh:

Year:  2018        PMID: 29362929     DOI: 10.1007/s00787-018-1109-0

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  27 in total

Review 1.  ADHD in parents.

Authors:  M Weiss; L Hechtman; G Weiss
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-08       Impact factor: 8.829

Review 2.  Molecular genetics of attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar
Journal:  Biol Psychiatry       Date:  2005-01-21       Impact factor: 13.382

3.  Effects of maternal stimulant medication on observed parenting in mother-child dyads with attention-deficit/hyperactivity disorder.

Authors:  Andrea Chronis-Tuscano; Mary Rooney; Karen E Seymour; Heather Jones Lavin; Jessica Pian; Adelaide Robb; Lisa Efron; Charles Conlon; Mark A Stein
Journal:  J Clin Child Adolesc Psychol       Date:  2010

4.  Does intensive multimodal treatment for maternal ADHD improve the efficacy of parent training for children with ADHD? A randomized controlled multicenter trial.

Authors:  Thomas Jans; Christian Jacob; Andreas Warnke; Ulrike Zwanzger; Silke Groß-Lesch; Swantje Matthies; Patricia Borel; Klaus Hennighausen; Barbara Haack-Dees; Michael Rösler; Wolfgang Retz; Alexander von Gontard; Susann Hänig; Esther Sobanski; Barbara Alm; Luise Poustka; Sarah Hohmann; Michael Colla; Laura Gentschow; Charlotte Jaite; Viola Kappel; Katja Becker; Martin Holtmann; Christine Freitag; Erika Graf; Gabriele Ihorst; Alexandra Philipsen
Journal:  J Child Psychol Psychiatry       Date:  2015-06-30       Impact factor: 8.982

5.  The relation between maternal ADHD symptoms & improvement in child behavior following brief behavioral parent training is mediated by change in negative parenting.

Authors:  Andrea Chronis-Tuscano; Kelly A O'Brien; Charlotte Johnston; Heather A Jones; Tana L Clarke; Veronica L Raggi; Mary E Rooney; Yamalis Diaz; Jessica Pian; Karen E Seymour
Journal:  J Abnorm Child Psychol       Date:  2011-10

Review 6.  Parent ADHD and Evidence-Based Treatment for Their Children: Review and Directions for Future Research.

Authors:  Andrea Chronis-Tuscano; Christine H Wang; Kelsey E Woods; Jennifer Strickland; Mark A Stein
Journal:  J Abnorm Child Psychol       Date:  2017-04

7.  A small-scale randomized controlled trial of the revised new forest parenting programme for preschoolers with attention deficit hyperactivity disorder.

Authors:  Margaret J J Thompson; Cathy Laver-Bradbury; Michelle Ayres; Emma Le Poidevin; Sarah Mead; Catherine Dodds; Lamprini Psychogiou; Paraskevi Bitsakou; David Daley; Anne Weeks; Laurie Miller Brotman; Howard Abikoff; Penny Thompson; Edmund J S Sonuga-Barke
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-04-30       Impact factor: 4.785

8.  Parenting in mothers with and without attention-deficit/hyperactivity disorder.

Authors:  Candice Murray; Charlotte Johnston
Journal:  J Abnorm Psychol       Date:  2006-02

Review 9.  Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments.

Authors:  Edmund J S Sonuga-Barke; Daniel Brandeis; Samuele Cortese; David Daley; Maite Ferrin; Martin Holtmann; Jim Stevenson; Marina Danckaerts; Saskia van der Oord; Manfred Döpfner; Ralf W Dittmann; Emily Simonoff; Alessandro Zuddas; Tobias Banaschewski; Jan Buitelaar; David Coghill; Chris Hollis; Eric Konofal; Michel Lecendreux; Ian C K Wong; Joseph Sergeant
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

10.  A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample.

Authors:  Alexandra Philipsen; Erika Graf; Thomas Jans; Swantje Matthies; Patricia Borel; Michael Colla; Laura Gentschow; Daina Langner; Christian Jacob; Silke Groß-Lesch; Esther Sobanski; Barbara Alm; Martina Schumacher-Stien; Michael Roesler; Wolfgang Retz; Petra Retz-Junginger; Bernhard Kis; Mona Abdel-Hamid; Viola Heinrich; Michael Huss; Catherine Kornmann; Arne Bürger; Ludger Tebartz van Elst; Mathias Berger
Journal:  Atten Defic Hyperact Disord       Date:  2013-10-17
View more
  4 in total

1.  Are childhood and adult ADHD the same entities?

Authors:  Alan Apter
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-07       Impact factor: 4.785

Review 2.  Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Kim Boesen; Asger Sand Paludan-Müller; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2022-02-24

3.  Examining the autistic traits in children and adolescents diagnosed with attention-deficit hyperactivity disorder and their parents.

Authors:  Esra Okyar; Işık Görker
Journal:  BMC Psychiatry       Date:  2020-06-05       Impact factor: 3.630

4.  Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017.

Authors:  Jørn Henrik Vold; Christer Aas; Svetlana Skurtveit; Ingvild Odsbu; Fatemeh Chalabianloo; Johan Reutfors; Anne Halmøy; Kjell Arne Johansson; Lars Thore Fadnes
Journal:  BMJ Open       Date:  2020-08-07       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.